Large-scale testing (Phase 3)Study completedNCT02137772
What this trial is testing
Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Who this might be right for
Prevention of CMV Infection or Disease
Merck Sharp & Dohme LLC 570